PH15001A - Prolactin secretion inhibitors - Google Patents

Prolactin secretion inhibitors

Info

Publication number
PH15001A
PH15001A PH21417A PH21417A PH15001A PH 15001 A PH15001 A PH 15001A PH 21417 A PH21417 A PH 21417A PH 21417 A PH21417 A PH 21417A PH 15001 A PH15001 A PH 15001A
Authority
PH
Philippines
Prior art keywords
secretion inhibitors
prolactin secretion
prolactin
inhibitors
secretion
Prior art date
Application number
PH21417A
Inventor
Ronald G Babington
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Priority claimed from US05/904,191 external-priority patent/US4202897A/en
Publication of PH15001A publication Critical patent/PH15001A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PH21417A 1977-07-25 1976-07-24 Prolactin secretion inhibitors PH15001A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US81842077A 1977-07-25 1977-07-25
US86236677A 1977-12-20 1977-12-20
US89129978A 1978-03-29 1978-03-29
US05/904,191 US4202897A (en) 1977-07-25 1978-05-11 Prolactin secretion inhibitors

Publications (1)

Publication Number Publication Date
PH15001A true PH15001A (en) 1982-03-22

Family

ID=27505854

Family Applications (1)

Application Number Title Priority Date Filing Date
PH21417A PH15001A (en) 1977-07-25 1976-07-24 Prolactin secretion inhibitors

Country Status (9)

Country Link
JP (1) JPS5444032A (en)
AU (1) AU3829978A (en)
DE (1) DE2830610A1 (en)
FR (1) FR2398499A1 (en)
GB (1) GB2001531A (en)
IL (1) IL55208A0 (en)
IT (1) IT7850363A0 (en)
NL (1) NL7807804A (en)
PH (1) PH15001A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2853409A1 (en) * 1977-12-20 1979-06-21 Sandoz Ag ANTI-PARKINSON COMPOSITIONS
IT1215261B (en) * 1985-04-05 1990-01-31 Poli Ind Chimica Spa PHARMACEUTICAL COMPOSITIONS ANTIGALACTOPOIETIC ADAPTITY.
TWI461426B (en) * 2009-05-27 2014-11-21 Merck Sharp & Dohme (dihydro)imidazoiso[5,1-a]quinolines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7117207A (en) * 1970-12-24 1972-06-27
FI370674A7 (en) * 1974-01-02 1975-07-03 Sandoz Ag

Also Published As

Publication number Publication date
DE2830610A1 (en) 1979-02-08
AU3829978A (en) 1980-01-31
JPS5444032A (en) 1979-04-07
IL55208A0 (en) 1978-09-29
GB2001531A (en) 1979-02-07
IT7850363A0 (en) 1978-07-19
FR2398499A1 (en) 1979-02-23
NL7807804A (en) 1979-01-29
FR2398499B1 (en) 1981-02-06

Similar Documents

Publication Publication Date Title
NZ183536A (en) N-(w-aminoalkyl) heterocycles
PH12008A (en) Complement inhibitors
JPS52107314A (en) Coospinning method
AU2631977A (en) Penicillins
PH15306A (en) Testosterone-5-alpah-reductase inhibitors
CH614991A5 (en) Facility for setting down objects
JPS5313656A (en) Sulfilimines as early vulcanization inhibitors
IE45293L (en) Penicillins
PT66392B (en) Cephalosporin
AU2409477A (en) Inhibitor
JPS5350770A (en) Time indication method
JPS52137097A (en) Marcerizing method
JPS52139111A (en) Additives for glazes
JPS52155383A (en) Aparratus for crossslinking
JPS5377223A (en) Additives for cement
GB1552896A (en) Artifical reveration apparatus
JPS5283894A (en) 88thiomethyl ergoline
ZA773324B (en) Nitrogen heterocycles
JPS52148874A (en) Automatic filterrhydroextractor
JPS5299116A (en) Typeing method
JPS52142480A (en) Liquiddgrowth method
JPS5294204A (en) Photooengraving method
JPS52142636A (en) Photooetching method
JPS5377221A (en) Additives for cement
JPS5377222A (en) Additives for cement